BAHD1 promotes osetosarcoma recurrence by enhancing tumor cell escape from chemotherapy-induced senescence

Author:

zhang liang1,luo dan1,zhang jian1,zhu jun1,gan yibo1,Zhao Jianhua1,Liu Mingyong1

Affiliation:

1. Army Medical University

Abstract

Abstract Objective To investigate the role and mechanism of BAHD1 in the proliferation and migration of osteosarcoma cells escaping from senescence. Methods Osteosarcoma cell lines U2OS and MG63 were cultured in vitro. Doxorubicin (DOX) and cisplatin induced U2OS and MG63 into a senescent state. The medium without DOX and CIS was replaced for continuous culture. Some cells were observed to proliferate again, which were defined as senescence-escaped OS cells (SEOS). The DOX group and CIS group were divided respectively. The DOX and CIS groups are divided into: the parent U2OS group, the U2OS SEOS cells at the 9th passage group, the parent MG63 group, and the MG63 SEOS cells at the 9th passage group. The expression of BAHD1 was detected by qRT PCR, Western blot and immunofluorescence. Cell count, CCK-8 test, agarose clone formation test, flow cytometry, etc. were used to detect cell proliferation. Cell Migration Assay was used to detect cell migration. Tumor Xenografts was used to detect the ability of cells to form tumors. The effect of BAHD1 was detected by RNA interference assay. Results The expression of BAHD1, cell cycle related proteins YWHAZ, CCND1 and stem cell factor KLF4 were significantly increased in SEOS cells at the 9th passage group compared with the parent group. Cell cycle enters S phase more quickly. After knockdown of BAHD1 expression, the above results were significantly recalled, and the ability of migration, cloning and tumor formation was significantly reduced. Conclusion The increased expression of BAHD1 is crucial in the progression of osteosarcoma, which may be achieved by up regulating the cell cycle related proteins YWHAZ, CCND1 and stem cell factor KLF4.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3